Xiaoling Jiang
9 Jinsui Rd
Guangzhou, 510623, China
Guangzhou, 510623, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Successful in situ 5-aminolevulinic acid photodynamic therapy in a 53-year-old female with cutaneous squamous cell carcinoma.
Journal: Journal of Zhejiang University. Science. B
Published: September 23, 2025
A Randomized, Investigator-Blinded, Split-Face, Controlled Trial Evaluating the Efficacy and Satisfaction of a Topical Product Containing Blueberry Extract and Pro-Xylane Combined With Micro-Focused Ultrasound for Anti-aging.
Journal: Journal of cosmetic dermatology
Published: December 17, 2024
Clinical characteristics and induced pluripotent stem cells (iPSCs) disease model of Harel-Yoon syndrome caused by compound heterozygous ATAD3A variants.
Journal: Human cell
Published: November 01, 2024
Mechanisms underlying the efficacy and limitation of dopa and tetrahydrobiopterin therapies for the deficiency of GTP cyclohydrolase 1 revealed in a novel mouse model.
Journal: European journal of pharmacology
Published: September 24, 2023
Single-nucleus RNA sequencing reveals cell type-specific transcriptome alterations of Down syndrome hippocampus using the Dp16 mouse model.
Journal: Genes & genomics
Published: October 02, 2022
A GM1 gangliosidosis mutant mouse model exhibits activated microglia and disturbed autophagy.
Journal: Experimental biology and medicine (Maywood, N.J.)
Published: February 15, 2021
Distinct severity of phenotype in Hajdu-Cheney syndrome: a case report and literature review.
Journal: BMC musculoskeletal disorders
Published: October 08, 2019
HOXA9 rs3801776 G>A polymorphism increases congenital talipes equinovarus risk in a Chinese population.
Journal: The journal of gene medicine
Published: April 02, 2019
A novel GTPCH deficiency mouse model exhibiting tetrahydrobiopterin-related metabolic disturbance and infancy-onset motor impairments.
Journal: Metabolism: clinical and experimental
Published: December 07, 2018
EGFR inhibitor gefitinib regulates barrier function in human epidermal keratinocytes via the modulation of the expression of claudins.
Journal: International journal of molecular medicine
Published: July 02, 2018
Last Updated: 09/26/2026